AC Immune SA (ACIU)
2.35
-0.03
(-1.26%)
USD |
NASDAQ |
Apr 19, 16:00
2.35
0.00 (0.00%)
After-Hours: 19:51
AC Immune Price to Book Value: 1.215 for April 19, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 1.231 |
| April 17, 2024 | 1.251 |
| April 16, 2024 | 1.267 |
| April 15, 2024 | 1.303 |
| April 12, 2024 | 1.417 |
| April 11, 2024 | 1.412 |
| April 10, 2024 | 1.448 |
| April 09, 2024 | 1.448 |
| April 08, 2024 | 1.448 |
| April 05, 2024 | 1.422 |
| April 04, 2024 | 1.422 |
| April 03, 2024 | 1.448 |
| April 02, 2024 | 1.396 |
| April 01, 2024 | 1.412 |
| March 28, 2024 | 1.531 |
| March 27, 2024 | 1.567 |
| March 26, 2024 | 1.469 |
| March 25, 2024 | 1.500 |
| March 22, 2024 | 1.588 |
| March 21, 2024 | 1.629 |
| March 20, 2024 | 1.683 |
| March 19, 2024 | 1.738 |
| March 18, 2024 | 1.810 |
| March 15, 2024 | 1.810 |
| March 14, 2024 | 1.722 |
| Date | Value |
|---|---|
| March 13, 2024 | 1.919 |
| March 12, 2024 | 1.815 |
| March 11, 2024 | 1.774 |
| March 08, 2024 | 1.961 |
| March 07, 2024 | 2.012 |
| March 06, 2024 | 2.012 |
| March 05, 2024 | 2.049 |
| March 04, 2024 | 1.888 |
| March 01, 2024 | 1.997 |
| February 29, 2024 | 1.878 |
| February 28, 2024 | 2.028 |
| February 27, 2024 | 1.966 |
| February 26, 2024 | 1.955 |
| February 23, 2024 | 1.784 |
| February 22, 2024 | 1.701 |
| February 21, 2024 | 1.732 |
| February 20, 2024 | 1.727 |
| February 16, 2024 | 1.587 |
| February 15, 2024 | 1.561 |
| February 14, 2024 | 1.473 |
| February 13, 2024 | 1.468 |
| February 12, 2024 | 1.504 |
| February 09, 2024 | 1.406 |
| February 08, 2024 | 1.468 |
| February 07, 2024 | 1.380 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7361
Minimum
Dec 22 2022
3.597
Maximum
Dec 29 2023
1.669
Average
1.584
Median
Jun 13 2019
Price to Book Value Benchmarks
| Roche Holding AG | 5.557 |
| CRISPR Therapeutics AG | 2.481 |
| Addex Therapeutics Ltd | 4.401 |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | 0.5709 |
Price to Book Value Related Metrics
| Price | 2.35 |
| Earnings Yield | -30.19% |
| Market Cap | 232.41M |